IPSC - Century Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

IPSC is currently covered by 7 analysts with an average price target of $12.08. This is a potential upside of $9.2 (319.44%) from yesterday's end of day stock price of $2.88.

Century Therapeutics's activity chart (see below) currently has 6 price targets and 24 ratings on display. The stock rating distribution of IPSC is 94.74% BUY and 5.26% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 7.14% with an average time for these price targets to be met of 27.29 days.

Highest price target for IPSC is $13, Lowest price target is $5, average price target is $12.08.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 12-Apr-2024. First documented stock forecast 13-Jul-2021.

Currently out of the existing stock ratings of IPSC, 18 are a BUY (94.74%), 1 are a HOLD (5.26%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$6.04 (204.05%)

10

16 days ago

0/5 (0%)

$5.09 (130.18%)

Hold

5

$2.04 (68.92%)

40

8 months ago

1/2 (50%)

$2.49 (99.20%)

191

Buy

13

$10.04 (339.19%)

17

8 months 18 days ago

0/6 (0%)

$10.29 (379.70%)

Buy

11 months 13 days ago

0/1 (0%)

$5.81 (20.61%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IPSC (Century Therapeutics) average time for price targets to be met?

On average it took 27.29 days on average for the stock forecasts to be realized with a an average price target met ratio 7.14

Which analyst has the current highest performing score on IPSC (Century Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on IPSC (Century Therapeutics) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on IPSC (Century Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on IPSC

Which analyst is the currently most bullish on IPSC (Century Therapeutics)?

Bill Maughan with highest potential upside - $26

Which analyst is the currently most reserved on IPSC (Century Therapeutics)?

Geulah Livshits with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?